Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
British Journal of Dermatology2018Vol. 180(5), pp. 1069–1076
Citations Over TimeTop 10% of 2018 papers
Richard B. Warren, Antonia Marsden, Barbara Tomenson, K.J. Mason, Moetaza M. Soliman, A. David Burden, Nick J. Reynolds, Deborah Stocken, Richard Emsley, C.E.M. Griffiths, Catherine Smith
Abstract
Psoriasis phenotype and potentially modifiable factors are associated with poor outcomes with biologics, underscoring the need for lifestyle management. Effect sizes suggest that these factors alone cannot inform treatment selection.
Related Papers
- → Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron Cohort Study(2017)84 cited
- → Factors encouraging cohort maintenance in a longitudinal study(1991)54 cited
- → Profile of vitamin D in a cohort of physicians and diabetologists in Kolkata(2012)23 cited
- → Vitamin D deficiency is less common among HIV-infected African–American men than in a matched cohort(2011)11 cited
- → Cohort profile: COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study(2020)